29th International Society of Cardiovascular Pharmacotherapy Annual Scientific Meeting

Program


*Subject to chance without notice.

Nov 1st

Time Topic Speaker Debater Moderator
08h00 Solenidade de Abertura      
08h30 - 08h45 Opening Conference I: “Prof Henry H. Neufeld”. Innovative and Efficient Clinical Trial Models with Pharmacological Interventions for Cardiovascular Diseases. Prof. Dr. Otavio Berwanger     
08h45 - 09h00 Opening Conference II "The Era of Direct Oral Anticoagulants: The importance of Getting the Right Dose Prof. Dr. Renato Lopes    
09h00 - 10h00 Lipid-lowering therapy      Dr. Francisco Fonseca
09h00 - 09h15 Lipid-lowering targets and therapy in patients with ACS and CCS  Dra. Maria Cristina Izar    
09h15 - 09h30 Lipid-lowering targets and therapy in patients with DM  Dr. Alberto Lorenzatti     
09h30 - 09h45 What should we do when statins are not enough? Dr. Antony Martínez-Rubio     
09h45 - 10h00 Debate      
10h00 - 10h30 Coffee Break      
10h30 - 11h30 Satellite Symposium Medtronic Dr. Celso Amodeo    
10h30 - 10h45 Fundamentos da RDN: A hiperatividade simpática renal como fator gerador de HTA resistente Dr. Luciano Drager    
10h45 - 11h05  Evidência clínica do procedimento de DNR com o cateter Symplicity Spyral: Um novo dispositivo com uma tecnica otimizada. Dr. Valério Fucs    
11h05 - 11h20 Critério de seleção do paciente com HTA resistente candidato a DNR: O que dizem as diretrizes e consensos atuais? Dr. João Vicente    
11h20 - 11h30 Discussão Todos
11h30 - 12h30 JOINT SESSION ISCP-SIAC
Personalized Medicine: the Future is Now
    Dr. Alvaro Sosa Liprandi

Pablo Avanza
11h30 - 11h45 New Strategies for Resistant Hypertension Dr. Thomas Kahan     
11h45 - 12h00 Polypill in Clinical Practice: What are we Waiting For?  Dr. Alvaro Sosa Liprandi    
12h00 - 12h15 Familial Hypercholesterolemia, new Opportunities for Difficult Patients Dr. Rodrigo Alonso     
12h15 - 12h30 Debate   Dra. Maria Cristina Izar

Dr. Luiz Bortolotto
 
12h30 - 13h30 Satellite Symposium Mantecorp: "Differences in Vitamin D and its benefits for cardiovascular health." Dr. Francisco Fonseca   Dr. Celso Amodeo
13h30 - 14h30 Combination of antihypertensive medications  Dr. Wilson Nadruz

Dr. Audes Feitosa
   
14h30 - 15h30 Satellite Symposium GSK - Cardiovascular outcomes associated with infections and the role of immunization in protecting cardiac patients. Dra. Maisa Kairalla
Dr. José Carlos da Costa Zanon
   
15h30 - 16h00 Coffee Break      
16h00 - 17h00 Heart Failure Session      
16h00 - 16h15 Pharmacological Pillars of HFrEF therapy Dr. Felipe Martinez    
16h15 - 16h30 Advanced Pharmacological approuch in HFpEF Dr. Francisco Saraiva    
16h30 - 16h45 Acta non Verba: barriers in implementing GDMT IN HFrEF management   Dr. George Dan    
16h45 - 17h00 Debate   Dr. Evandro Tinoco

Dr. Felix Ramires
 
17h00 - 18h00 Miscellaneous topics: Hormones and Drugs     Dr. Audes Feitosa
17h00 - 17h15 The impact new generations (GLP-1 agonists and dual GIP/GLP-1 agonisms) on weight and CV outcomes Dr. Francisco Saraiva    
17h15 - 17h30 Benefits of beta-3 adrenergic agonism on the CV system Dra. Andrea Brandão    
17h30 - 17h45 Cardiovascular disease in transgender individuals Dr. Wilson Nadruz    
17h45 - 18h00 Debate   Dr. Abrão Cury

Dr Oswaldo Passarelli Jr
 
18h00 - 19h00 Atrial Fibrillation Session     Dr. Weverton Leite
18h00 - 18h15 DOACs use in AF in 2024  Dr. Alvaro Avezum    
18h15 - 18h30 Antithrombotic strategies after ACS and AF Dr. Luis Machado    
18h30 - 18h45 Reversion or heart rate control in patients with AF?  Dr. Tasso Lobo    
18h45 - 19h00 Debate   Dr. Nelson Siqueira  

  Scientific Session
  Scientific Session
  Coffe Break
  Satellite Symposium

Nov 2nd

Time Topic Speaker Debater Moderator
08h30 - 09h30 JOINT SESSION ISCP-WHF Pharmacotherapy Potpourri     Dr. Evandro Tinoco

Dr. Alvaro Sosa Liprandi
08h30 - 08h45 HF Prevention, What is in the Horizon? Dr. Felipe Martínez     
08h45 - 09h00 Flu Shot and CV Disease, as Important as Statin?  Dr. Alvaro Sosa Liprandi    
09h00 - 09h15 Novel Oral Anticoagulants and Emerging Agents  Dr. Antony Martínez-Rubio     
09h15 - 09h30 Debate   Dr. Thomas Kaham

Dr. Pablo Avanzas
 
09h30 - 10h30 Innovations in vascular ageing and hypertension     Dr. Mauricio Wangarten
09h30 - 10h00 Oscillometric devices for vascular ageing and central blood pressure parameters and evaluation  Dr. Weimar K. Sebba Barroso de Souza    
10h00 - 10h15 Emerging antihypertensive classes: What can we expect for the future?  Dr. Wilson Nadruz    
10h15 - 10h30 RNA interference strategies for the treatment of hypertension Dr. Luciano Drager    
10h30 - 11h00 Coffee Break      
11h00 - 12h00 Inflammation in CVD     Dr. Ricardo Pavanello
11h00 - 11h15 Anti-Inflammatory therapy in atherosclerosis Dr. Francisco Fonseca    
11h15 - 11h30 Colchicine in chronic and acute coronary syndromes Dr. Otavio Rizzi Coelho     
11h30 - 11h45 Anti-Inflammatory therapy in HF Dr. Koji Hasegawa    
11h45 - 12h00 Debate   Dr. Luis Gowdak

Dr. Antonio Carlos Pallandri Chagas
 
12h00 - 13h00 Satellite symposium Daiichi-Sankyo: "The future of hypertension: Olmesartan triple therapy and orodispersible pharmaceutical technology." Dr. Celso Amodeo    
13h00 - 14h00 Metabolic Associated Fatty Liver Disease (MAFLD)     Dr. Abrão Cury
13h00 - 13h15 How to diagnosis MAFLD Dr. Bruno Geloneze    
13h15 - 13h45 MAFLD and CV risk  and therapy Dr. Franscisco Saraiva    
13h45 - 14h00 Debate   Dra. Egle Costa  
14h00 - 15h00 Antithrombotics     Dr. Edson Stefanini
14h00 - 14h15 Drugs Interactions of DOACS Dra. Doreen Tan    
14h15 - 14h30 Bleeding risk and reversers of antithrombotics  Dr. Luis Fernando Tanajura    
14h30 - 14h45 Warfarin indications in 2024  Dr. Pavanello    
14h45 - 15h00 Debate   Dr. Antony Martínez-Rubio  
15h00 - 16h00 JOINT SESSION ISCP/SBC
Cardiovascular Prevention
    Dr. Antonio Carlos Pallandri Chagas
15h00 - 15h15 Cognitive decline and brain damage: How to evaluate?  Dr. Weimar K. Sebba Barroso de Souza    
15h15 - 15h30 Polypills in Hypertension  Dra. Andrea Brandão    
15h30 - 15h45 Refractory Angine: New Concepts Dr. Juan Carlos Kaski    
15h45 - 16h00 Debate   Dr. Ricardo Pavanello

Dr. Evandro Tinoco
 
16h00 - 17h00 Cardiomyopathies Therapy     Dr. Fabio Fernandes
16h00 - 16h15 Hypertrophic cardiomyopathy  Dr. Dirceu Rodrigues de Almeida    
16h15 - 16h30 Amyloidosis Dra. Edileide Barros    
16h30 - 16h45 Cardiac manifestations of sarcoidosis and potential impact of treatment Dr. Fabio Fernandes    
16h45 - 17h00 Pharmacological Pillars of HFmrEF therapy Dr. Fernando Bacal    
17h00 - 18h00 Obesity and cardiovascular health: challenges e solutions in the XXI century      Dr. Celso Amodeo
17h00 - 17h20 Bariatric surgery: what are the indications in 2024? Dr. Luciano Drager    
17h20 - 17h40 Pipeline and perpectives for new molecules  Dr. Bruno Geloneze     
17h40 - 18h00 Discussion      

  Scientific Session
  Scientific Session
  Coffe Break
  Satellite Symposium